Plus, news about Evotec, Bristol Myers Squibb and Precigen:
Roivant hints at another deal: The drugmaker may make an addition to its pipeline, saying it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.